Smoking cessation in women: Special considerations

CNS Drugs

Volumn 15, Issue 5, 2001, Pages 391-411

  Perkins, Kenneth A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CLONIDINE; COTININE; FLUOXETINE; MECAMYLAMINE; NALTREXONE; NICOTINE; NICOTINE GUM; NORTRIPTYLINE;

ASSOCIATION; CLINICAL TRIAL; DEPRESSION; DRUG INDUCED DISEASE; FEMALE; HEALTH HAZARD; HUMAN; MALE; MENSTRUAL CYCLE; META ANALYSIS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING CESSATION; SOCIAL SUPPORT; TRANSDERMAL PATCH; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0035009429     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200115050-00005     Document Type: Review

References (139)

1. 1. Peto R, Lopez AD, Boreham J, et al. Mortality from smoking worldwide. Br Med Bull 1996; 52: 12-21
2. 2. Amos A. Women and smoking. Br Med Bull 1996; 52: 74-89
3. 3. Lopez AD, Collishaw NE, Piha T. A descriptive model of the cigarette epidemic in developed countries. Tob Control 1994; 3: 242-7
4. 4. U.S. Department of Health and Human Services. Reducing the health consequences of smoking: a report of the Surgeon General. Washington DC: U.S. Government Printing Office, 1989
5. 5. Cavelaars AEJM, Kunst AE, Geurts JJM, et al. Educational differences in smoking: international comparison. BMJ 2000; 320: 1102-7
6. 6. Grunberg NE, Winders SE, Wewers ME. Gender differences in tobacco use. Health Psychol 1991; 10: 143-53
7. 7. Fiore MC. Trends in cigarette smoking in the United States. Med Clin North Am 1992; 76: 289-303
8. 8. Wald NJ, Hacksaw AK. Cigarette smoking: an epidemiological overview. Br Med Bull 1996; 52: 3-11
9. 9. Ernster VL, Grady D, Miike R, et al. Facial wrinkling in men and women, by smoking status. Amer J Publ Health 1995; 85: 78-82
10. 10. Sacks JJ, Nelson DE. Smoking and injuries: an overview. Prev Med 1994; 23: 515-20
11. 11. Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043-7
12. 12. Baron JA, La Vecchia C, Levi F. The anti-estrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990; 162: 502-14
13. 13. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996; 88: 183-92
14. 14. Risch HA, Howe GR, Jain M, et al. Are female smokers at higher risk for lung cancer than male smokers: a case-control analysis by histologic type. Am J Epidemiol 1993; 138: 281-93
15. 15. Prescott E, Osler M, Hein HO, et al. Gender and smoking-related risk of lung cancer. Epidemiology 1998; 9: 79-83
16. 16. Osann KE, Anton Culver H, Kurosaki T, et al. Gender differences in lung cancer risk associated with cigarette smoking. Int J Cancer 1993; 54: 44-8
17. 17. Siegfried JM, Davis ALG, Gupta C. Role of estrogens in non-small cell lung cancer [abstract]. Proc Am Assoc Cancer Res 2000; 41: 138
18. 18. Mollerup S, Ryberg D, Hewer A, et al. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999; 59: 3317-20
19. 19. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994; 7: 477-83
20. 20. Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997; 10: 822-7
21. 21. Morabia A, Berstein M, Heritier S, et al. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 1996; 143: 918-28
22. 22. Hornsby PP, Wilcox AJ, Weinberg CR. Cigarette smoking and disturbance of menstrual function. Epidemiology 1998; 9: 193-8
23. 23. Hughes EG, Brennan BG. Does cigarette smoking impair natural or assisted fecundity? Fertil Steril 1996; 66: 679-89
24. 24. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985; 103: 350-6
25. 25. Haglund B, Cnattingius S. Cigarette smoking as a risk factor for sudden infant death syndrome: a population-based study. Am J Pub Health 1990; 80: 29-32
26. 26. Blake SV, Gurrin LC, Evans SF, et al. Maternal cigarette smoking during pregnancy, low birth weight, and subsequent blood pressure in early childhood. Early Hum Dev 2000; 57: 137-47
27. 27. Olds DL, Henderson CR, Tatelbaum R. Intellectual impairment in children of women who smoke cigarettes during pregnancy. Pediatrics 1994; 93: 221-7
28. 28. Orlebecke JF, Knol DL, Verhulst FC. Child behavior problems increased by maternal smoking during pregnancy. Arch Environ Health 1999; 54: 15-9
29. 29. Kandel DB, Wu P, Davies M. Maternal smoking during pregnancy and smoking by adolescent daughters. Am J Pub Health 1994; 84: 1407-13
30. 30. Oncken CA. Toxicity and physiologic effects of nicotine during pregnancy. Presented at the Alternative Nicotine Delivery Systems Conference; 1997 Mar 21-23; Toronto
31. 31. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990; 322: 213-7
32. 32. Wilson K, Gibson N, Williams A, et al. Effect of smoking cessation on mortality after myocardial infarction. Arch Intern Med 2000; 160: 939-44
33. 33. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269: 232-6
34. 34. Ockene JK. Smoking among women across the lifespan: prevalence, interventions, and implications for cessation research. Ann Behav Med 1993; 15: 135-48
35. 35. Swan GE, Ward MN, Carmelli D, et al. Differential rates of relapse in subgroups of male and female smokers. J Clin Epidemiol 1993; 46: 1041-53
36. 36. Fortmann SP, Killen JD. Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies. Am J Epidemiol 1994; 140: 39-51
37. 37. Kabat GC, Wynder EL. Determinants of quitting smoking. Am J Publ Health 1987; 77: 1301-5
38. 38. Ward KD, Klesges RC, Zbikowski SM, et al. Gender differences in the outcome of an unaided smoking cessation attempt. Addict Behav 1997; 22: 521-33
39. 39. Bjornson W, Rand C, Connett JE, et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Pub Health 1995; 85: 223-30
40. 40. Gourlay SG, Forbes A, Marriner T, et al. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994; 309: 842-6
41. 41. Royce JM, Corbett K, Sorensen G, et al. Gender, social pressure, and smoking cessation: the community intervention trial for smoking cessation (COMMIT) at baseline. Soc Sci Med 1997; 44: 359-70
42. 42. Senore C, Battista RN, Shapiro SH, et al. Predictors of smoking cessation following physicians' counseling. Prev Med 1998; 27: 412-21
43. 43. Wetter D, Kenford SL, Smith SS, et al. Gender differences in smoking cessation. J Consult Clin Psychol 1999; 67: 555-62
44. 44. Centers for Disease Control. Surveillance for selected tobacco-use behaviors - United States, 1900-1994. Morbid Mortal Wkly Rep 1994; 43: 1-43
45. 45. Burt RD, Peterson AV. Smoking cessation among high school seniors. Prev Med 1998; 27: 319-27
46. 46. Patton GC, Carlin JB, Coffey C, et al. The course of early smoking: a population-based cohort study over three years. Addict 1998; 93: 1251-60
47. 47. Sussman S, Dent CW, Severson H, et al. Self-initiated quitting among adolescent smokers. Prev Med 1998; 27 Suppl.: A19-A28
48. 48. Gritz ER, Thompson B, Emmons K, et al. Gender differences among smokers and quitters in the Working Well Trial. Prev Med 1998; 27: 553-61
49. 49. Whitlock EP, Vogt TM, Mollis JF, et al. Does gender affect response to a brief clinic-based smoking intervention? Am J Prev Med 1997; 13: 159-66
50. 50. U.S. Department of Health and Human Services. The health consequences of smoking: nicotine addiction. Washington, DC: U.S. Government Printing Office, 1988
51. 51. Svikis DS, Hatsukami DK, Hughes JR, et al. Sex differences in the tobacco withdrawal syndrome. Addict Behav 1986; 11: 459-62
52. 52. Pomerleau CS. Smoking and nicotine replacement treatment issues specific to women. Am J Health Behav 1996; 20: 291-9
53. 53. Pomerleau CS, Tate JC, Lumley MA, et al. Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms. J Subst Abuse 1994; 6: 433-40
54. 54. Zhu S, Melcer T, Sun J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000; 18: 305-11
55. 55. Blake SM, Klepp K-I, Pechacek TF, et al. Differences in smoking cessation strategies between men and women. Addict Behav 1989; 14: 409-18
56. 56. Rogers LQ, Johnson KC, Young ZM, et al. Demographic bias in physician smoking cessation counseling. Am J Med Sci 1997; 313: 153-8
57. 57. Young JM, Ward JE. Influence of physician and patient gender on provision of smoking cessation advice in general practice. Tob Control 1998; 7: 360-3
58. 58. Woolverton WL, Nader MA. Experimental evaluation of the reinforcing effects of drugs. In: Adler M, Cowan A, editors. Modern methods in pharmacology. Vol. 6. New York: Wiley-Liss, Inc., 1992: 165-92
59. 59. Shiffman S, Gnys M, Richards TJ, et al. Temptations to smoke after quitting: a comparison of lapsers and maintainers. Health Psychol 1996; 15: 455-61
60. 60. Killen JD, Fortmann SP, Newman B, et al. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 1990; 58: 85-92
61. 61. Perkins KA, Donny E, Caggiula AR. Sex differences in nicotine effects and self-administration: human and animal evidence. Nicotine Tob Res 1999; 1: 301-5
62. 62. Perkins KA, Gerlach D, Vender J, et al. Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine Tob Res. In press
63. 63. Robbins SJ, Ehrman RN, Childress AR, et al. Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend 1999; 53: 223-30
64. 64. Sofuoglu M, Dudish-Poulsen S, Nelson D, et al. Gender differences in the subjective effects from multiple deliveries of smoked cocaine in humans. Exp Clin Psychopharmacol 1999; 7: 274-83
65. 65. Fagerstrom K-O Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation. Prev Med 1984; 13: 517-27
66. 66. Murray RP, Voelker HT, Rakos, RF, et al. Intervention for relapse to smoking: the Lung Health Study Restart Programs. Addict Behav 1997; 22: 281-6
67. 67. Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993; 153: 1881-90
68. 68. Davis LJ, Hurt RD, Offord KP, et al. Self-administered nicotine-dependence scale (SANDS): item selection, reliability estimation, and initial validation. J Clin Psychol 1994; 50: 918-30
69. 69. Swan GE, Jack LM, Ward MM. Subgroups of smokers with different success rates after use of transdermal nicotine. Addict 1997; 92: 207-18
70. 70. Russell MAH, Stapleton JA, Feyerabend C, et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ 1993; 306: 1308-12
71. 71. Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counseling. JAMA 1995; 274: 1347-52
72. 72. Sonderskov J, Olsen J, Sabroe S, et al. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997; 145: 309-18
73. 73. Blondal T. Controlled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med 1989; 149: 1818-21
74. 74. Fortmann SP, Killen JD. Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. J Consult Clin Psychol 1995; 63: 460-8
75. 75. Hjalmarson A, Nilsson F, Sjostrom L, et al. The nicotine inhaler in smoking cessation. Arch Intern Med 1997; 157: 1721-8
76. 76. Jackson PH, Stapleton JA, Russell MAH, et al. Predictors of outcome in a general practitioner intervention against smoking. Prevent Med 1986; 15: 244-53
77. 77. Glover ED, Sachs DPL, Stitzer ML, et al. Smoking cessation in highly dependent smokers with 4 mg nicotine polacrilex. Am J Health Behav 1996; 20: 319-32
78. 78. Norregaard J, Tonnesen P, Petersen L. Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med 1993; 22: 261-71
79. 79. Stapleton JA, Russell MAH, Feyerabend C, et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995; 90: 31-42
80. 80. West R, Hajek P, Nilsson F, et al. Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology 2001; 15: 225-30
81. 81. Perkins KA. Sex differences in nicotine versus non-nicotine reinforcement as determinants of tobacco smoking. Exp Clin Psychopharmacol 1996; 4: 166-77
82. 82. Gariti P, Alterman AI, Barber W, et al. Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an out-patient treatment setting. Drug Alcohol Depend 1999; 54: 111-6
83. 83. Gourlay SG, Forbes A, Marriner T, et al. Predictors and timing of adverse experiences during transdermal nicotine therapy. Drug Saf 1999; 20: 545-55
84. 84. Perkins KA. Nicotine discrimination in men and women. Pharmacol Biochem Behav 1999; 64: 295-9
85. 85. Hatsukami D, Skoog K, Allen S, et al. Gender and the effects of different doses of nicotine gum on tobacco withdrawal symptoms, Exp Clin Psychopharmacol 1995; 3: 163-73
86. 86. Wetter D, Fiore MC, Young TB, et al. Gender differences in response to nicotine replacement therapy: objective and subjective indices of tobacco withdrawal. Exp Clin Psychopharmacol 1999; 7: 135-44
87. 87. Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 2000; 295: 321-7
88. 88. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-202
89. 89. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-91
90. 90. Lerman C, Audrain J, Crystal S, et al. Gender differences in response to bupropion for smoking cessation [abstract]. Proceedings of the 7th Annual Meeting of the Society for Research on Nicotine and Tobacco; 2001 Mar 23-25; Seattle (WA)
91. 91. Rose JE, Behm FM, Westman EC. Brand-switching and gender effects in mecamylamine/nicotine smoking cessation treatment [abstract]. Proceedings of the 5th Annual Meeting of the Society for Research on Nicotine and Tobacco; 1999 Mar 5-7; San Diego (CA)
92. 92. Gourlay S, Benowitz NL. Is clonidine an effective smoking cessation therapy? Drugs 1995; 50: 197-207
93. 93. Classman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine. JAMA 1988; 259: 2863-6
94. 94. Franks P, Harp J, Bell B. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting. JAMA 1989; 262; 3011-3
95. 95. Villagra VG, Rosenberger JL, Girolami S. Transdermal clonidine for smoking cessation: a randomized, double-blind, placebo controlled trial [abstract]. Circulation 1989; 80 Suppl. 11: 58
96. 96. Prochazka AV, Petty TL, Nett L, et al. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation. Arch Intern Med 1992; 152: 2065-9
97. 97. Glassman AH, Covey LS, Dalack GW, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993; 54: 670-9
98. 98. Hilleman DE, Mohiuddin SM, Delcore MG, et al. Randomized, controlled trial of transdermal clonidine for smoking cessation. Ann Pharmacother 1993; 27: 1025-8
99. 99. Hall SM, Reus VI, Munoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683-90
100. 100. Covey LS, Glassman AH, Stetner F. Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis 1999; 18: 31-40
101. 101. Covey LS, Glassman AH. A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation. Br J Addict 1991; 86: 991-8
102. 102. Gourlay S, Forbes A, Marriner T, et al. A placebo-controlled study of three clonidine doses for smoking cessation. Clin Pharmacol Ther 1994; 55: 64-9
103. 103. Pohl R, Yeragani. VK, Balon R, et al. Smoking in patients with panic disorder. Psychiatry Res 1992; 43: 253-62
104. 104. Cinciripini PM, Lapitsky L, Seay S, et al. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high-and low-anxiety smokers. J Clin Psychopharmacol 1995; 15: 182-91
105. 105. Borland R. Slip-ups and relapse in attempts to quit smoking. Addict Behav 1990; 15: 235-45
106. 106. Blondal T, Gudmundsson LJ, Tomasson K, et al. The effects of fluoxetine combined with nicotine inhalers in smoking cessation: a randomized trial. Addict 1999; 94: 1007-15
107. 107. Hitsman B, Pingitore R, Spring B, et al. Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 1999; 67: 547-54
108. 108. Berlin I, Said S, Spreuxvaroquaux O, et al. A reversible monoamine-oxidase-A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 1995; 58: 444-52
109. 109. Almeida LEF, Pereira EFR, Alkondon M, et al. The opioid antagonist naltrexone inhibits activity and alters expression of alpha 7 and alpha 4/beta 2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs. Neuropharmacol 2000; 39: 2740-55
110. 110. Hutchison KE, Monti PM, Rohsenow DJ, et al. Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results. Psychopharmacol 1999; 142: 139-43
111. 111. Pirie PL, Murray DM, Luepker RV. Smoking and quitting in a cohort of young adults. Am J Pub Health 1991; 81: 324-7
112. 112. Nides M, Rand C, Dolce J, et al. Weight gain as a function of smoking cessation and 2-mg nicotine gum use among middle-aged smokers with mild lung impairment in the first 2 years of the Lung Health Study. Health Psychol 1994; 13: 354-61
113. 113. Weekley CK, Klesges RC, Relyea G. Smoking as a weight-control strategy and its relationship to smoking status. Addict Behav 1992; 17: 259-71
114. 114. Pinto BM, Borrelli B, King TK, et al. Weight control smoking among sedentary women. Addict Behav 1999; 24: 75-86
115. 115. Meyérs AW, Klesges RC, Winders SE, et al. Are weight concerns predictive of smoking cessation? A prospective analysis. J Consult Clin Psychol 1997; 66: 448-52
116. 116. Mizes JS, Sloan DM, Segraves K, et al. The influence of weight-related variables on smoking cessation. Behav Ther 1998; 29: 371-85
117. 117. Perkins KA, Levine M, Marcus MD, et al. Addressing women's concerns about weight gain due to smoking cessation. J Subst Abuse Treat 1997; 14: 1-10
118. 118. Doherty K, Militello FS, Kinnunen T, et al. Nicotine gum dose and weight gain after smoking cessation. J Consult Clin Psychol 1996; 64: 799-807
119. 119. Jorenby DE, Hatsukami DK, Smith SS, et al. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology 1996; 128: 130-8
120. 120. Rigotti NA, Thorndike AN, Durcan MJ, et al. Post-cessation weight gain in smokers taking bupropion: the effect of gender [abstract]. Proceedings of the 6th Annual Meeting of the Society for Research on Nicotine and Tobacco; 2000 Feb 18-20; Arlington (VA)
121. 121. Spring B, Wurtman J, Wurtman R, et al. Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation. Am J Clin Nutr 1995; 62: 1181-7
122. 122. Hall SM, Tunstall CD, Vila KL, et al. Weight gain prevention and smoking cessation: cautionary findings. Am J Pub Health 1992; 82: 799-803
123. 123. Pirie PL, McBride CM, Hellerstedt W, et al. Smoking cessation in women concerned about weight. Am J Pub Health 1992; 82: 1238-43
124. 124. Marcus BH, Albrecht AE, King TK, et al. The efficacy of exercise as an aid for smoking cessation in women. Arch Intern Med 1999; 159: 1229-34
125. 125. Perkins KA, Marcus MD, Levine MD, et al. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. J Consult Clin Psychol. In press
126. 126. Mielke MM, Jorenby DE, Fiore MC. Achieving smoking cessation in nicotine-dependent individuals. CNS Drugs 1997; 8: 12-20
127. 127. Benowitz NL. Nicotine replacement therapy during pregnancy. JAMA 1991; 266: 3174-7
128. 128. Wright LN, Thorp JM, Kuller JA, et al. Trandermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. Am J Obstet Gynecol 1997; 176: 1090-4
129. 129. O'Hara P, Portser SA, Anderson BP. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addict Behav 1989; 14: 595-600
130. 130. Perkins KA, Levine M, Marcus M, et al. Menstrual cycle phase and tobacco withdrawal after quitting smoking. J Consult Clin Psychol 2000; 68: 176-80
131. 131. Burger J, Gochfeld M. Gender differences in smoking behavior in a university workplace. Sex Roles 1989; 20: 523-33
132. 132. Murray RP, Johnston JJ, Dolce JJ, et al. Social support for smoking cessation and abstinence: the Lung Health study. Addict Behav 1995; 20: 159-70
133. 133. Sidney S, Tekawa I, Friedman G. Mentholated cigarette use among multiphasic examinees, 1979-86. Am J Pub Health 1989; 79: 1415-6
134. 134. Parrott AC, Craig D. Psychological functions served by nicotine chewing gum. Addict Behav 1995; 20: 271-8
135. 135. Shiffman S. Smoking cessation treatment: any progress? J Consult Clin Psychol 1993; 61: 718-22
136. 136. Perkins KA, Hickox M, Grobe JE. Behavioral economics of smoking. In: Bickel W, Vuchinich R, editors. Reframing health behavior change with behavioral economics. Mahwah (NJ): Erlbaum, 2000: 265-92
137. 137. Niaura R, Shadel WG, Abrams DB, et al. Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. Addict Behav 1998; 23: 209-24
138. 138. Grobe JE, Perkins KA. Interaction of gender and the controllability over tobacco intake [abstract]. Proceedings of the 6th Annual Meeting of the Society for Research on Nicotine and Tobacco; 2000 Feb 18-20: Arlington (VA)
139. 139. Cinciripini PM, Lapitsky L, Seay S, et al. The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? J Consult Clin Psychol 1995; 63: 388-99